Soligenix Inc (SNGX)
0.352
-0.04
(-10.43%)
USD |
NASDAQ |
May 23, 16:00
0.3547
0.00 (0.00%)
After-Hours: 19:03
Soligenix Free Cash Flow: -7.780M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.780M |
| December 31, 2023 | -8.604M |
| September 30, 2023 | -10.40M |
| June 30, 2023 | -10.97M |
| March 31, 2023 | -11.58M |
| December 31, 2022 | -12.66M |
| September 30, 2022 | -12.09M |
| June 30, 2022 | -11.88M |
| March 31, 2022 | -11.00M |
| December 31, 2021 | -11.74M |
| September 30, 2021 | -12.81M |
| June 30, 2021 | -12.76M |
| March 31, 2021 | -12.74M |
| December 31, 2020 | -11.46M |
| September 30, 2020 | -9.980M |
| June 30, 2020 | -9.047M |
| March 31, 2020 | -7.918M |
| December 31, 2019 | -7.510M |
| September 30, 2019 | -7.542M |
| June 30, 2019 | -6.452M |
| March 31, 2019 | -8.079M |
| December 31, 2018 | -7.247M |
| September 30, 2018 | -6.913M |
| June 30, 2018 | -7.158M |
| March 31, 2018 | -6.369M |
| Date | Value |
|---|---|
| December 31, 2017 | -6.537M |
| September 30, 2017 | -5.620M |
| June 30, 2017 | -5.612M |
| March 31, 2017 | -5.976M |
| December 31, 2016 | -4.990M |
| September 30, 2016 | -4.90M |
| June 30, 2016 | -4.038M |
| March 31, 2016 | -4.533M |
| December 31, 2015 | -5.408M |
| September 30, 2015 | -4.445M |
| June 30, 2015 | -5.105M |
| March 31, 2015 | -3.628M |
| December 31, 2014 | -2.518M |
| September 30, 2014 | -3.445M |
| June 30, 2014 | -4.164M |
| March 31, 2014 | -4.138M |
| December 31, 2013 | -4.475M |
| September 30, 2013 | -3.517M |
| June 30, 2013 | -2.528M |
| March 31, 2013 | -2.709M |
| December 31, 2012 | -2.640M |
| September 30, 2012 | -3.520M |
| June 30, 2012 | -0.0511M |
| March 31, 2012 | -1.078M |
| December 31, 2011 | -2.104M |
Free Cash Flow Range, Past 5 Years
-12.81M
Minimum
Sep 2021
-6.452M
Maximum
Jun 2019
-10.35M
Average
-10.99M
Median
Free Cash Flow Benchmarks
| Eagle Pharmaceuticals Inc | -- |
| Marinus Pharmaceuticals Inc | -113.98M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.342M |
| Cash from Financing (Quarterly) | -0.009M |
| Free Cash Flow Per Share (Quarterly) | -0.1276 |
| Free Cash Flow to Equity (Quarterly) | -1.078M |
| Free Cash Flow to Firm (Quarterly) | -1.342M |
| Free Cash Flow Yield | -229.3% |